PRAMEF12 (PRAME family member 12) is a cancer/testis antigen with restricted expression in normal tissues, limited to the human testis 1. The protein functions as a component of ubiquitin-dependent protein degradation pathways, participating in Cul2-RING ubiquitin ligase complexes [GO annotations]. In spermatogenesis, PRAMEF12 is essential for maintaining the spermatogenic lineage; genetic ablation in mice arrests spermatogenesis, results in sterility, and reduces spermatogonial stem cell populations with decreased expression of SSC maintenance-related genes 2. The deficiency phenotype mirrors Sertoli cell-only syndrome observed in human male infertility 2. In cancer biology, PRAMEF12 demonstrates significant diagnostic value for glioma; knockdown inhibits cell proliferation, induces apoptosis, and causes S-phase cell cycle arrest 1. PRAMEF12 interacts with MAGE-B4, a cancer-testis antigen, though MAGE-B4 itself is dispensable for mouse spermatogenesis 3. Pathway enrichment analyses implicate PRAMEF12 in ubiquitin-mediated protein degradation and cancer-related signaling 1. These findings establish PRAMEF12 as a potential diagnostic biomarker for glioma with dual roles in reproductive biology and cancer pathogenesis.